Manesh Patel and C. Michael Gibson discuss the results of a phase II trial comparing the safety profiles of asundexian versus apixaban in patients with atrial fibrillation.
Want to check another podcast?
Enter the RSS feed of a podcast, and see all of their public statistics.
